Top Markets
Coin of the day
ProUroCare Medical Inc. ProUroCare Medical Inc.

ProUroCare Medical Inc.

PUMD
Rang in Aktien #42361
ProUroCare Medical Inc. is dedicated to developing advanced products for the... ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$1.86K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-50.00%
Land
US
Handel ProUroCare Medical Inc. (PUMD)

Kategorie

EPS für ProUroCare Medical Inc. (PUMD)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von ProUroCare Medical Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von ProUroCare Medical Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber